If there weren’t so many rookie medical mistakes in the arguments against this technology I might be worried
But the lack of science and the failure to even state correctly the blood circulation of a human being show the level of accuracy in these arguments. It’s sadly and almost childishly very poor.
To not know how the chemotherapy will be administered in this trial is beyond belief.
To not understand the difference between a consent form and an informed consent displays a complete lack of understanding about the clinical trial procedure that is so flawed it exposes all the other objections.
It confirms my belief that the technology is sound.
I accept that it’s development wasn’t as fast as they hoped.
I accept that share price is falling due to multi million company sales.
And I note that tens of millions of shares are being bought each day at these record lows
People don’t just buy shares at this price without knowing for sure that this stands a legitimate chance of being a success.
Just as eminent oncologists don’t waste their time on a technology just to make money.
News 
Market Data 
Discover 
AI
